Calamos Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,447
Closed -$671K 341
2021
Q4
$671K Sell
1,447
-56
-4% -$23.6K 0.05% 199
2021
Q3
$560K Hold
1,503
0.05% 212
2021
Q2
$574K Buy
+1,503
New +$574K 0.04% 214
2020
Q3
Sell
-947
Closed -$249K 264
2020
Q2
$249K Sell
947
-84
-8% -$22.4K 0.03% 235
2020
Q1
$234K Hold
1,031
0.04% 217
2019
Q4
$311K Buy
1,031
+21
+2% +$5.78K 0.04% 201
2019
Q3
$243K Hold
1,010
0.03% 209
2019
Q2
$285K Sell
1,010
-1,735
-63% -$474K 0.04% 195
2019
Q1
$788K Sell
2,745
-100
-4% -$28.9K 0.11% 137
2018
Q4
$747K Sell
2,845
-138
-5% -$37.9K 0.11% 132
2018
Q3
$817K Buy
2,983
+108
+4% +$28K 0.1% 126
2018
Q2
$684K Buy
+2,875
New +$666K 0.09% 134
2016
Q2
Sell
-11,361
Closed -$1.58M 243
2016
Q1
$1.58M Buy
11,361
+2,782
+32% +$372K 0.3% 109
2015
Q4
$1.2M Sell
8,579
-5,209
-38% -$718K 0.24% 132
2015
Q3
$1.93M Buy
13,788
+795
+6% +$119K 0.46% 69
2015
Q2
$2.13M Buy
12,993
+1,942
+18% +$310K 0.5% 61
2015
Q1
$1.71M Buy
+11,051
New +$1.57M 0.43% 88

Other funds holding ELV

Calamos Wealth Management's ELV Position: Q1 2022 in Review

Calamos Wealth Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 1,447 shares — an estimated $671K sold.

Calamos Wealth Management first reported a position in ELV in Q1 2015 and held it in 17 quarters. The position peaked at $2.13M in Q2 2015. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Calamos Wealth Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Calamos Wealth Management sold 1,447 Elevance Health shares in Q1 2022, an estimated $671K.
  • Calamos Wealth Management first reported a position in Elevance Health in Q1 2015 and held it in 17 quarters.
  • Calamos Wealth Management's Elevance Health position peaked at $2.13M in Q2 2015.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Calamos Wealth Management's 13F filing for Q1 2022, filed 3 May 2022.